Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135819![]() (US10085990, Example 103 | US10568888, Example 103 ...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135824![]() (US10085990, Example 127 | US10568888, Example 127 ...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135822![]() (US10085990, Example 121 | US10568888, Example 121 ...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135823![]() (US10085990, Example 122 | US10568888, Example 122 ...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 39 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135820![]() (US10085990, Example 115 | US10568888, Example 115 ...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 49 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135819![]() (US10085990, Example 103 | US10568888, Example 103 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135822![]() (US10085990, Example 121 | US10568888, Example 121 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 59 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135818![]() (US10085990, Example 92 | US10568888, Example 92 | ...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 68 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135824![]() (US10085990, Example 127 | US10568888, Example 127 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 73 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135816![]() (US10085990, Example 54 | US10568888, Example 54 | ...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 78 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135823![]() (US10085990, Example 122 | US10568888, Example 122 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 80 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135821![]() (US10085990, Example 118 | US10568888, Example 118 ...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 80 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135815![]() (US10085990, Example 51 | US10568888, Example 51 | ...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 126 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135818![]() (US10085990, Example 92 | US10568888, Example 92 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 151 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135820![]() (US10085990, Example 115 | US10568888, Example 115 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 163 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135821![]() (US10085990, Example 118 | US10568888, Example 118 ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 206 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135816![]() (US10085990, Example 54 | US10568888, Example 54 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 338 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135817![]() (US10085990, Example 84 | US10568888, Example 84 | ...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 513 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135815![]() (US10085990, Example 51 | US10568888, Example 51 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 616 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135817![]() (US10085990, Example 84 | US10568888, Example 84 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 827 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135814![]() (US10085990, Example 33 | US10568888, Example 33 | ...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.24E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135812![]() (US10085990, Example 30 | US10568888, Example 30 | ...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135813![]() (US10085990, Example 32 | US10568888, Example 32 | ...) | PDB Reactome pathway UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135814![]() (US10085990, Example 33 | US10568888, Example 33 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135813![]() (US10085990, Example 32 | US10568888, Example 32 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM135812![]() (US10085990, Example 30 | US10568888, Example 30 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
vTv Therapeutics LLC US Patent | Assay Description The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or Mn... | US Patent US10568888 (2020) BindingDB Entry DOI: 10.7270/Q2ST7S7B | |||||||||||
More data for this Ligand-Target Pair |